SHINGRIX Shingles Vaccine

1 in 3 people will get shingles in their lifetime.
SHINGRIX is a vaccine proven to be more than 90% effective in preventing shingles (herpes zoster) in adults 50 years and older in clinical trials.

SHINGRIX is given as a 2-dose series, with the second shot administered 2 to 6 months after the first shot. To get the protection against shingles offered by SHINGRIX, it’s important to get both shots

• You should not receive SHINGRIX if you are allergic to any of its ingredients or had an allergic reaction to a previous dose of SHINGRIX 
• An increased risk of Guillain-Barré syndrome (severe muscle weakness) was observed after vaccination with SHINGRIX 
• Fainting can happen after getting injectable vaccines, including SHINGRIX. 
• Precautions should be taken to avoid falling and injury due to fainting 
• The most common side effects are pain, redness, and swelling at the injection site, muscle pain, tiredness, headache, shivering, fever, and upset stomach 
• SHINGRIX was not studied in pregnant or nursing women. Tell your healthcare provider if you are pregnant, plan to become pregnant, or are breastfeeding

More Information
https://www.shingrix.com